NCT05066568

Brief Summary

Fibromyalgia is a public health condition, which causes great functional disability. Conventional treatment modalities have been shown a very poor therapeutic response, in that most individuals end up becoming poly-medicated and refractory to treatment. Non-pharmacological techniques with promising effects on the syndrome symptoms include both hypnotic analgesia and the transcranial direct-current stimulation (tDCS). Giving the treatment limitations of this syndrome its important to better understand the pain processess in fibromyalgia and treatments effect. This project was developed in order to evaluate the synergistic effect of a hypnotic analgesia suggestion associated with tDCS over pain levels and cortical excitability in individuals with fibromyalgia over a nociceptive stimulation pattern.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 4, 2021

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

October 4, 2021

Status Verified

September 1, 2021

Enrollment Period

1.3 years

First QC Date

August 23, 2021

Last Update Submit

September 24, 2021

Conditions

Keywords

chronic painfibromyalgiahypnotic analgesiatDCSDPMSCold pressor test

Outcome Measures

Primary Outcomes (3)

  • Changes in Pain Levels during Cold Pressor Test from Pre to Post Interventions

    Pain levels measured by a numerical visual analogue scale during Cold Pressor Test. The subject will have her hand submerged in cold water at 0 degrees celcius up to 2 minutes.

    First assessed 40 minutes Pre interventions and 70 minutes post interventions

  • Changes in Pain Tolerance during Cold Pressor Test from Pre to Post Interventions

    The time in the subject withstands with his hand submerged in cold water at 0 degrees celcius during Cold Pressor Test. With a maximum of 2 minutes.

    First assessed 40 minutes Pre interventions and again 70 minutes post interventions

  • Changes in Short Cortical Inhibition during Transcranial Magnetic Stimulation from pre to post interventions

    Short Cortical Inhibition measured by Transcranial Magnetic Stimulation. Using the MagOption for MagPro R30 and X100 device with electromyography.

    First assessed 10 minutes Pre intervention and again 20 minutes post intervention

Secondary Outcomes (5)

  • Changes in Numerical Pain Scale during Conditioned Pain Modulation-task from Pre to Post Interventions

    First assessed 50 minutes pre interventions and again 1 hour post interventions

  • Changes in Motor Threshold from Pre to Post Interventions

    First assessed 30 minutes Pre interventions and again immediately post interventions

  • Changes in Motor Evoked Potential from Pre to Post Interventions

    First assessed 25 minutes Pre interventions and again 5 minutes post interventions

  • Changes in Silent Period from Pre to Post Interventions

    First assessed 5 minutes Pre Interventions and again 25 minutes post interventions

  • Changes in Intra-cortical Facilitation from Pre to Post Interventions

    First assessed 10 minutes Pre intervention and again 20 minutes post intervention

Other Outcomes (5)

  • Pain Catastrophizing Scale

    5 minutes

  • Pittsburgh Sleep Quality Index

    5 minutes

  • Beck Depression Inventory II

    5 minutes

  • +2 more other outcomes

Study Arms (2)

Sequence of interventions starting with tDCS as the first intervention

OTHER

Week 1 Active tDCS left dorso-lateral prefrontal cortex. F3 anode F4 catode Area of electrodes: 35 cm2 Current intensity: 2mA Stimulation Time: 20min Week 2 Rest The subjects will be asked to remain seated and still for 20 minutes. Week 3 Hypnotic analgesia suggestion Classic approach. The intervention starts with a induction with suggestions for the subject to focus her attention in a single stimuli, combined with progressive relaxation. After that, direct suggestions are given for comfort and pain reduction. Intervention time: 20 minutes Week 4 Active tDCS + Hypnotic analgesia suggestion Intervention Time: 20 minutes. Week 5 Sham tDCS + Hypnotic analgesia suggestion The sham tDCS will have the same areas of stimulation of the active tDCS, but the device will turn itself out after 30 seconds. Intervention time: 20 minutes

Device: Active Tracranial Direct Current StimulationOther: Hypnotic analgesia suggestionBehavioral: RestOther: Active tDCS + Hypnotic analgesia suggestionOther: Sham tDCS + Hypnotic analgesia suggestion

Sequence of interventions starting with Hypnosis as the first intervention

OTHER

Week 1 Hypnotic analgesia suggestion Classic approach. The intervention starts with a induction with suggestions for the subject to focus her attention in a single stimuli, combined with progressive relaxation. After that, direct suggestions are given for comfort and pain reduction. Intervention time: 20 minutes Week 2 Rest The subjects will be asked to remain seated and still for 20 minutes. Week 3 Active tDCS left dorso-lateral prefrontal cortex. F3 anode F4 catode Area of electrodes: 35 cm2 Current intensity: 2mA Stimulation Time: 20min Week 4 Sham tDCS + Hypnotic analgesia suggestion The sham tDCS will have the same areas of stimulation of the active tDCS, but the device will turn itself out after 30 seconds. Intervention time: 20 minutes Week 5 Active tDCS + Hypnotic analgesia suggestion Intervention Time: 20 minutes.

Device: Active Tracranial Direct Current StimulationOther: Hypnotic analgesia suggestionBehavioral: RestOther: Active tDCS + Hypnotic analgesia suggestionOther: Sham tDCS + Hypnotic analgesia suggestion

Interventions

Site: dorsolateral prefrontal cortex. F3 anode and F4 catode. Electrode area: 35cm2 Current Intensity: 2mA Stimulation time: 20 min The current ramps up during 30 seconds reaching 2mA, staying this way until the last 30 seconds of stimulation, in wich the current slowly decreases to zero.

Also known as: a-tDCS
Sequence of interventions starting with Hypnosis as the first interventionSequence of interventions starting with tDCS as the first intervention

The hypnotic induction protocol was standardized to be applied equally to all subjects. The protocol for hypnotic analgesia begins with an induction with a sequence of suggestions for the subjects to focus their attention on an individual stimulus, associated with progressive relaxation. After that, direct suggestions are given for comfort and pain reduction. The intervention lasts 20 minutes, with 12 minutes of induction and 8 minutes of hypnotic suggestions to reduce pain and leave the trance.

Also known as: Hypnosis
Sequence of interventions starting with Hypnosis as the first interventionSequence of interventions starting with tDCS as the first intervention
RestBEHAVIORAL

The patient is asked to remain seated still for 20 minutes.

Sequence of interventions starting with Hypnosis as the first interventionSequence of interventions starting with tDCS as the first intervention

Site: dorsolateral prefrontal cortex. F3 anode and F4 catode. Electrode area: 35cm2 Current Intensity: 2mA Intervention time: 20 min The current ramps up during 30 seconds reaching 2mA, staying this way until the last 30 seconds of stimulation, in wich the current slowly decreases to zero. The hypnotic induction protocol was standardized to be applied equally to all subjects. The protocol for hypnotic analgesia begins with an induction with a sequence of suggestions for the subjects to focus their attention on an individual stimulus, associated with progressive relaxation. After that, direct suggestions are given for comfort and pain reduction. The intervention lasts 20 minutes, with 12 minutes of induction and 8 minutes of hypnotic suggestions to reduce pain and leave the trance.

Also known as: a-tDCS+HS
Sequence of interventions starting with Hypnosis as the first interventionSequence of interventions starting with tDCS as the first intervention

Site: dorsolateral prefrontal cortex. F3 anode and F4 catode. Electrode area: 35cm2 Current Intensity: 0mA Intervention time: 20 min The current is turned off after 30 seconds. The hypnotic induction protocol was standardized to be applied equally to all subjects. The protocol for hypnotic analgesia begins with an induction with a sequence of suggestions for the subjects to focus their attention on an individual stimulus, associated with progressive relaxation. After that, direct suggestions are given for comfort and pain reduction. The intervention lasts 20 minutes, with 12 minutes of induction and 8 minutes of hypnotic suggestions to reduce pain and leave the trance.

Also known as: s-tDCS+HS
Sequence of interventions starting with Hypnosis as the first interventionSequence of interventions starting with tDCS as the first intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women
  • Literate
  • Fibromyalgia diagnosis according to 2016 American College of Rheumatology criteria
  • Pain score ≥ 6 in the Numerical Pain Scale during most of the time in the last 3 months.
  • Score ≥ 8 /12 in the Waterloo-Stanford Group Hypnotic Susceptibility Scale C

You may not qualify if:

  • Contraindication to Transcranial Magnetic Stimulation
  • Metallic implant in brain
  • Medical implants in brain
  • Cardiac Pacemaker
  • Cochlear implant
  • History of drug or alcohol abuse in the last 6 months
  • Neurological disorders
  • History of head trauma or neurosurgery
  • Decompensated systemic diseases
  • Chronic inflammatory diseases (lupus, rheumatoid arthritis, Sjogren syndrome, Reiter syndrome)
  • Decompensated hypothyroidism
  • History of cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-003, Brazil

RECRUITING

Related Publications (1)

  • Schein B, Beltran G, Franca BR, Sanches PRS, Silva DP Jr, Torres IL, Fegni F, Caumo W. Effects of Hypnotic Analgesia and Transcranial Direct Current Stimulation on Pain Tolerance and Corticospinal Excitability in Individuals with Fibromyalgia: A Cross-Over Randomized Clinical Trial. J Pain Res. 2023 Jan 24;16:187-203. doi: 10.2147/JPR.S384373. eCollection 2023.

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Interventions

HypnosisRE1-silencing transcription factor

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Wolnei Caumo, PhD

    Federal University of Rio Grande do Sul

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wolnei Caumo, PHD

CONTACT

Bruno Schein Cavalheiro Corrêa, Bachelor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Blinding: The researcher will receive a device previously programmed by a research assistant. This way the researcher that perform the Transcranial direct current stimulation does not know if it's a active or sham intervention. The subjects will also be blinded to the nature of the stimulation. The subjects will be asked to answer what intervention they think they recieved after each one of the tDCS sessions.
Purpose
OTHER
Intervention Model
FACTORIAL
Model Details: Design: Randomized blinded factorial sham controlled clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2021

First Posted

October 4, 2021

Study Start

July 2, 2020

Primary Completion

October 30, 2021

Study Completion

December 30, 2021

Last Updated

October 4, 2021

Record last verified: 2021-09

Locations